The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 18, 2023

Filed:

Sep. 07, 2018
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Lingyin Li, Stanford, CA (US);

Mark Smith, San Francisco, CA (US);

Kelsey Erin Shaw, Atlanta, GA (US);

Jacqueline Ann Carozza, Stanford, CA (US);

Volker Boehnert, Palo Alto, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/675 (2006.01); A61P 35/00 (2006.01); C07D 401/04 (2006.01); C07F 5/02 (2006.01); C07F 9/00 (2006.01); C07F 9/09 (2006.01); C07F 9/165 (2006.01); C07F 9/38 (2006.01); C07F 9/44 (2006.01); A61K 31/519 (2006.01); C07F 9/40 (2006.01); A61K 31/517 (2006.01); C07D 401/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/675 (2013.01); A61P 35/00 (2018.01);
Abstract

Compounds, compositions and methods are provided for the inhibition of ENPP1. Aspects of the subject methods include contacting a sample with a ENPP1 inhibitor to inhibit cGAMP hydrolysis activity of ENPP1. In some cases, the ENPP1 inhibitor is cell impermeable. Also provided are compositions and methods for treating cancer. Aspects of the methods include administering to a subject a therapeutically effective amount of a ENPP1 inhibitor to treat the subject for cancer. In certain cases, the cancer is a solid tumor cancer. Also provided are methods of administering radiation therapy to a subject either before or after administering an ENPP1 inhibitor. The radiation therapy can be administered at a dosage and/or frequency effective to reduce radiation damage to the subject. In certain cases, the method is performed in combination with a chemotherapeutic agent, or a checkpoint inhibitor, or both.


Find Patent Forward Citations

Loading…